{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:22Z","timestamp":1795008562720,"version":"4.9.1"},"reference-count":164,"publisher":"European Respiratory Society (ERS)","issue":"161","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2021,4,2]]},"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:p>Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and\/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD. IPF is now the most common indication for LTx worldwide. Several unique features in patients with ILD can impact optimal timing of referral or listing for LTx, pre- or post-transplant risks, candidacy and post-transplant management. As the epidemiology of LTx and community practices have evolved, recent literature describes outcomes and approaches in higher-risk candidates. In this review, we discuss the unique and important clinical findings, course, monitoring and management of patients with IPF and other progressive fibrotic ILDs during pre-LTx evaluation and up to the day of transplantation; the need for co-management with clinical experts in ILD and LTx is emphasised. Some post-LTx complications are unique in these patient cohorts, which require prompt detection and appropriate management by experts in multiple disciplines familiar with telomere biology disorders and infectious, haematological, oncological and cardiac complications to enhance the likelihood of improved outcomes and survival of LTx recipients with IPF and other ILDs.<\/jats:p>","DOI":"10.1183\/16000617.0017-2021","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T06:25:14Z","timestamp":1628058314000},"page":"210017","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["Lung transplantation for interstitial lung disease"],"prefix":"10.1183","volume":"30","author":[{"given":"Siddhartha G.","family":"Kapnadak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"2024102403560862000_30.161.210017.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.08.001"},{"key":"2024102403560862000_30.161.210017.2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.healun.2020.07.009","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report \u2013 2020; focus on deceased donor characteristics","volume":"39","author":"Chambers","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl. s1","key":"2024102403560862000_30.161.210017.3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.15677","article-title":"OPTN\/SRTR 2018 annual data report: lung","volume":"20","author":"Valapour","year":"2020","journal-title":"Am J Transplant"},{"key":"2024102403560862000_30.161.210017.4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2019.11.003","article-title":"Validating thoracic simulated allocation model predictions for impact of broader geographic sharing of donor lungs on transplant waitlist outcomes","volume":"39","author":"Lehr","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.healun.2018.09.007","article-title":"Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes","volume":"38","author":"Mooney","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.6","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00020-2017"},{"key":"2024102403560862000_30.161.210017.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00600-7"},{"key":"2024102403560862000_30.161.210017.8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1513\/AnnalsATS.201606-507OC","article-title":"Survival benefit of lung transplantation in the modern era of lung allocation","volume":"14","author":"Vock","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403560862000_30.161.210017.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06405-2"},{"key":"2024102403560862000_30.161.210017.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2024102403560862000_30.161.210017.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"2024102403560862000_30.161.210017.12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.chest.2019.12.031","article-title":"Counterpoint: should every patient with idiopathic pulmonary fibrosis be referred for transplant evaluation? No","volume":"157","author":"Glanville","year":"2020","journal-title":"Chest"},{"key":"2024102403560862000_30.161.210017.13","doi-asserted-by":"crossref","unstructured":"Leard LE , Holm A , Valapour M , et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021; in press [https:\/\/doi.org\/10.1016\/j.healun.2021.07.005].","DOI":"10.1016\/j.healun.2021.07.005"},{"key":"2024102403560862000_30.161.210017.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.06.014"},{"key":"2024102403560862000_30.161.210017.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1002"},{"key":"2024102403560862000_30.161.210017.16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1183\/09031936.02.00182002","article-title":"Clinical significance of histological classification of idiopathic interstitial pneumonia","volume":"19","author":"Flaherty","year":"2002","journal-title":"Eur RespirJ"},{"key":"2024102403560862000_30.161.210017.17","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9704130"},{"key":"2024102403560862000_30.161.210017.18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1378\/chest.12-0298","article-title":"Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis","volume":"142","author":"Brown","year":"2012","journal-title":"Chest"},{"key":"2024102403560862000_30.161.210017.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"2024102403560862000_30.161.210017.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2024102403560862000_30.161.210017.21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-2600(16)30326-5","article-title":"Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis","volume":"5","author":"Nathan","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102403560862000_30.161.210017.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103690"},{"key":"2024102403560862000_30.161.210017.23","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209701"},{"key":"2024102403560862000_30.161.210017.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.10.015"},{"key":"2024102403560862000_30.161.210017.25","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018"},{"key":"2024102403560862000_30.161.210017.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200607-912OC"},{"key":"2024102403560862000_30.161.210017.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02718-2020"},{"key":"2024102403560862000_30.161.210017.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102403560862000_30.161.210017.29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102403560862000_30.161.210017.30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12890-017-0462-y","article-title":"Exploring efficacy and safety of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) \u2013 a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial","volume":"17","author":"Behr","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2024102403560862000_30.161.210017.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2024102403560862000_30.161.210017.32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"2024102403560862000_30.161.210017.33","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00148613"},{"key":"2024102403560862000_30.161.210017.34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pulmoe.2019.08.007","article-title":"Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis","volume":"26","author":"Alberti","year":"2020","journal-title":"Pulmonology"},{"key":"2024102403560862000_30.161.210017.35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/tri.12913","article-title":"Transplant size mismatch in restrictive lung disease","volume":"30","author":"Ganapathi","year":"2017","journal-title":"Transpl Int"},{"key":"2024102403560862000_30.161.210017.36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1513\/AnnalsATS.201810-713OC","article-title":"Association between allosensitization and waiting list outcomes among adult lung transplant candidates in the United States","volume":"16","author":"Tague","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403560862000_30.161.210017.37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201507-1279OC","article-title":"Short stature and access to lung transplantation in the United States. A cohort study","volume":"193","author":"Sell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403560862000_30.161.210017.38","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213620"},{"key":"2024102403560862000_30.161.210017.39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12931-019-1043-9","article-title":"Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry","volume":"20","author":"Snyder","year":"2019","journal-title":"Respir Res"},{"key":"2024102403560862000_30.161.210017.40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.athoracsur.2015.06.024","article-title":"Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200211-1311OC"},{"key":"2024102403560862000_30.161.210017.42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.05.020","article-title":"Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: a cohort study","volume":"154","author":"Ratwani","year":"2019","journal-title":"Respir Med"},{"key":"2024102403560862000_30.161.210017.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"2024102403560862000_30.161.210017.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201007-1179OC"},{"key":"2024102403560862000_30.161.210017.45","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1790OC"},{"key":"2024102403560862000_30.161.210017.46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.chest.2020.03.037","article-title":"Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype","volume":"158","author":"Inoue","year":"2020","journal-title":"Chest"},{"key":"2024102403560862000_30.161.210017.47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/resp.13387","article-title":"Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis","volume":"24","author":"Yoon","year":"2019","journal-title":"Respirology"},{"key":"2024102403560862000_30.161.210017.48","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181cf1ee1"},{"key":"2024102403560862000_30.161.210017.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01681.x"},{"key":"2024102403560862000_30.161.210017.50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.healun.2014.09.028","article-title":"Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry","volume":"34","author":"Hayanga","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.51","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.21037\/jtd.2017.08.31","article-title":"Lung transplantation in elderly patients","volume":"9","author":"Courtwright","year":"2017","journal-title":"J Thorac Dis"},{"key":"2024102403560862000_30.161.210017.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.08.032"},{"key":"2024102403560862000_30.161.210017.53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.healun.2020.10.009","article-title":"Risk factors for mortality in lung transplant recipients aged \u226565\u2005years: a retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients","volume":"40","author":"Mosher","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.healun.2020.11.011","article-title":"Is chronological age still a hard selection criterion for lung transplantation?","volume":"40","author":"Schweiger","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0425OC"},{"key":"2024102403560862000_30.161.210017.56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.healun.2018.07.015","article-title":"Pre-transplant weight loss and clinical outcomes after lung transplantation","volume":"37","author":"Clausen","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.21037\/jtd.2018.02.50","article-title":"Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation","volume":"10","author":"Park","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024102403560862000_30.161.210017.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.01.858"},{"key":"2024102403560862000_30.161.210017.59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2016.12.013","article-title":"Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease","volume":"36","author":"Courtwright","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.60","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.transproceed.2014.09.163","article-title":"Is lung transplantation a valuable therapeutic option for patients with pulmonary polymyositis? Experiences from the Leuven transplant cohort","volume":"46","author":"Ameye","year":"2014","journal-title":"Transplant Proc"},{"key":"2024102403560862000_30.161.210017.61","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3182676089"},{"key":"2024102403560862000_30.161.210017.62","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182845f23"},{"key":"2024102403560862000_30.161.210017.63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1513\/AnnalsATS.201512-806OC","article-title":"Lung transplant outcomes in systemic sclerosis with significant esophageal dysfunction. A comprehensive single-center experience","volume":"13","author":"Miele","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403560862000_30.161.210017.64","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1513\/AnnalsATS.201503-177OC","article-title":"Lung transplant in patients with scleroderma compared with pulmonary fibrosis. Short- and long-term outcomes","volume":"13","author":"Crespo","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403560862000_30.161.210017.65","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.athoracsur.2017.09.038","article-title":"Long-term survival in bilateral lung transplantation for scleroderma-related lung disease","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.healun.2018.03.003","article-title":"Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study","volume":"37","author":"Prad\u00e8re","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.67","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/resp.13671","article-title":"Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis","volume":"25","author":"Wajda","year":"2020","journal-title":"Respirology"},{"key":"2024102403560862000_30.161.210017.68","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00408-015-9781-z","article-title":"Long-term survival after lung transplantation in patients with silicosis and other occupational lung disease","volume":"193","author":"Hayes","year":"2015","journal-title":"Lung"},{"key":"2024102403560862000_30.161.210017.69","doi-asserted-by":"crossref","first-page":"e13460","DOI":"10.1111\/ctr.13460","article-title":"Outcomes after lung transplantation for patients with occupational lung diseases","volume":"33","author":"Joubert","year":"2019","journal-title":"Clin Transplant"},{"key":"2024102403560862000_30.161.210017.70","doi-asserted-by":"crossref","first-page":"e229402","DOI":"10.1136\/bcr-2019-229402","article-title":"Pleuroparenchymal fibroelastosis (PPFE) treated with lung transplantation and review of the literature","volume":"12","author":"Ali","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2024102403560862000_30.161.210017.71","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1378\/chest.14-1543","article-title":"Lung transplantation for hypersensitivity pneumonitis","volume":"147","author":"Kern","year":"2015","journal-title":"Chest"},{"key":"2024102403560862000_30.161.210017.72","first-page":"92","article-title":"Lung transplantation for pulmonary sarcoidosis","volume":"36","author":"Meyer","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403560862000_30.161.210017.73","first-page":"117","article-title":"Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis","volume":"25","author":"Wille","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403560862000_30.161.210017.74","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207497"},{"key":"2024102403560862000_30.161.210017.75","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.219.2.r01ma12503"},{"key":"2024102403560862000_30.161.210017.76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102403560862000_30.161.210017.77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66370"},{"key":"2024102403560862000_30.161.210017.78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10555-016-9633-1","article-title":"Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications","volume":"35","author":"Boscolo-Rizzo","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"2024102403560862000_30.161.210017.79","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200804-550OC"},{"key":"2024102403560862000_30.161.210017.80","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-3078"},{"key":"2024102403560862000_30.161.210017.81","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00308-2016"},{"key":"2024102403560862000_30.161.210017.82","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403560862000_30.161.210017.83","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","article-title":"Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival","volume":"36","author":"Newton","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.84","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00060014"},{"key":"2024102403560862000_30.161.210017.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.11.010"},{"key":"2024102403560862000_30.161.210017.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.05.002"},{"key":"2024102403560862000_30.161.210017.87","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200605-587ST"},{"key":"2024102403560862000_30.161.210017.88","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01204-2015"},{"key":"2024102403560862000_30.161.210017.89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/lungindia.lungindia_275_20","article-title":"Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP)","volume":"37","author":"Singh","year":"2020","journal-title":"Lung India"},{"key":"2024102403560862000_30.161.210017.90","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0044-2019"},{"key":"2024102403560862000_30.161.210017.91","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1811737","article-title":"Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis","volume":"379","author":"Kolb","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102403560862000_30.161.210017.92","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.healun.2019.06.014","article-title":"Single lung transplantation in patients with severe secondary pulmonary hypertension","volume":"38","author":"Nasir","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.93","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1594"},{"key":"2024102403560862000_30.161.210017.94","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.healun.2014.09.004","article-title":"Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the United Network of Organ Sharing registry","volume":"34","author":"Hayes","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.10.014"},{"key":"2024102403560862000_30.161.210017.96","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024102403560862000_30.161.210017.97","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018"},{"key":"2024102403560862000_30.161.210017.98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.healun.2005.07.012","article-title":"Effect of pre-transplantation prednisone on survival after lung transplantation","volume":"25","author":"McAnally","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.99","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00316-8"},{"key":"2024102403560862000_30.161.210017.100","doi-asserted-by":"crossref","first-page":"P268","DOI":"10.1016\/j.healun.2017.07.002","article-title":"Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy","volume":"37","author":"Leuschner","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.101","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2019.02.005","article-title":"Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving antifibrotics: experience of the Australian Lung Transplant Collaborative","volume":"38","author":"Mackintosh","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.102","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14873"},{"key":"2024102403560862000_30.161.210017.103","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1150OC"},{"key":"2024102403560862000_30.161.210017.104","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.201409-1698OC","article-title":"The utility of preoperative six-minute-walk distance in lung transplantation","volume":"192","author":"Castleberry","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403560862000_30.161.210017.105","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.10.041"},{"key":"2024102403560862000_30.161.210017.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.06.005"},{"key":"2024102403560862000_30.161.210017.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.03.006"},{"key":"2024102403560862000_30.161.210017.108","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.21037\/jtd.2016.07.06","article-title":"Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients","volume":"8","author":"Lee","year":"2016","journal-title":"J Thorac Dis"},{"key":"2024102403560862000_30.161.210017.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.04.002"},{"key":"2024102403560862000_30.161.210017.110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5500\/wjt.v6.i3.517","article-title":"Physical rehabilitation for lung transplant candidates and recipients: an evidence-informed clinical approach","volume":"6","author":"Wickerson","year":"2016","journal-title":"World J Transplant"},{"key":"2024102403560862000_30.161.210017.111","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.6.9804105"},{"key":"2024102403560862000_30.161.210017.112","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.6.1932"},{"key":"2024102403560862000_30.161.210017.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.07.033"},{"key":"2024102403560862000_30.161.210017.114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","article-title":"Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study","volume":"46","author":"Richardson","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2024102403560862000_30.161.210017.115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00341.x"},{"key":"2024102403560862000_30.161.210017.116","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-2600(18)30301-1","article-title":"Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial","volume":"6","author":"Raghu","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102403560862000_30.161.210017.117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.healun.2014.09.005","article-title":"Pre-transplant impedance measures of reflux are associated with early allograft injury after lung transplantation","volume":"34","author":"Lo","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2011.04.035"},{"key":"2024102403560862000_30.161.210017.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.05.040"},{"key":"2024102403560862000_30.161.210017.120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11605-015-2983-0","article-title":"Both pre-transplant and early post-transplant antireflux surgery prevent development of early allograft injury after lung transplantation","volume":"20","author":"Lo","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"2024102403560862000_30.161.210017.121","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.jtcvs.2018.02.009","article-title":"Early fundoplication is associated with slower decline in lung function after lung transplantation in patients with gastroesophageal reflux disease","volume":"155","author":"Biswas Roy","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403560862000_30.161.210017.122","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI"},{"key":"2024102403560862000_30.161.210017.123","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.chest.2018.06.027","article-title":"Effect of acute exacerbation of idiopathic pulmonary fibrosis on lung transplantation outcome","volume":"154","author":"Dotan","year":"2018","journal-title":"Chest"},{"key":"2024102403560862000_30.161.210017.124","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0319"},{"key":"2024102403560862000_30.161.210017.125","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0132-2019"},{"key":"2024102403560862000_30.161.210017.126","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.09.117"},{"key":"2024102403560862000_30.161.210017.127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ajt.14422","article-title":"Mechanical ventilation and extracorporeal membrane oxygenation as a bridging strategy to lung transplantation: significant gains in survival","volume":"18","author":"Hayanga","year":"2018","journal-title":"Am J Transplant"},{"key":"2024102403560862000_30.161.210017.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.06.026"},{"key":"2024102403560862000_30.161.210017.129","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201109-1599OC"},{"key":"2024102403560862000_30.161.210017.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.06.009"},{"key":"2024102403560862000_30.161.210017.131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.athoracsur.2016.11.056","article-title":"Awake extracorporeal membrane oxygenation as bridge to lung transplantation: a 9-year experience","volume":"104","author":"Biscotti","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.132","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1513\/AnnalsATS.201804-258OC","article-title":"Procedure preference and intention-to-treat outcomes after listing for lung transplantation among U.S. adults. A cohort study","volume":"16","author":"Anderson","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403560862000_30.161.210017.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.014"},{"key":"2024102403560862000_30.161.210017.134","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.healun.2015.12.030","article-title":"Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently listed for single and double lung transplantation","volume":"35","author":"Chauhan","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.09.062"},{"key":"2024102403560862000_30.161.210017.136","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivr085"},{"key":"2024102403560862000_30.161.210017.137","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-11-200912010-00004"},{"key":"2024102403560862000_30.161.210017.138","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1371"},{"key":"2024102403560862000_30.161.210017.139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1175"},{"key":"2024102403560862000_30.161.210017.140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.athoracsur.2018.04.060","article-title":"Single- versus double-lung transplantation in pulmonary fibrosis: impact of age and pulmonary hypertension","volume":"106","author":"Villavicencio","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.141","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.athoracsur.2015.05.008","article-title":"What is the optimal transplant for older patients with idiopathic pulmonary fibrosis?","volume":"100","author":"Gulack","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.142","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.athoracsur.2014.05.072","article-title":"Double lung transplants have significantly improved survival compared with single lung transplants in high lung allocation score patients","volume":"98","author":"Black","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.143","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart-lung transplant report \u2013 2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102403560862000_30.161.210017.144","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315511"},{"key":"2024102403560862000_30.161.210017.145","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200805-725OC"},{"key":"2024102403560862000_30.161.210017.146","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv461"},{"key":"2024102403560862000_30.161.210017.147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035611"},{"key":"2024102403560862000_30.161.210017.148","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.5.551"},{"key":"2024102403560862000_30.161.210017.149","doi-asserted-by":"crossref","first-page":"e13026","DOI":"10.1111\/ctr.13026","article-title":"Postoperative outcomes and management strategies for coronary artery disease in patients in need of a lung transplantation","volume":"31","author":"Khandhar","year":"2017","journal-title":"Clin Transplant"},{"key":"2024102403560862000_30.161.210017.150","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00107514"},{"key":"2024102403560862000_30.161.210017.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.04.044"},{"key":"2024102403560862000_30.161.210017.152","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jtcvs.2019.10.185","article-title":"Fundoplication to preserve allograft function after lung transplant: systematic review and meta-analysis","volume":"160","author":"Davidson","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403560862000_30.161.210017.153","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2003.166"},{"key":"2024102403560862000_30.161.210017.154","doi-asserted-by":"crossref","first-page":"e13065","DOI":"10.1111\/ctr.13065","article-title":"Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery \u2013 a single-center experience of 412 consecutive patients","volume":"31","author":"Hirji","year":"2017","journal-title":"Clin Transplant"},{"key":"2024102403560862000_30.161.210017.155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-0012.2011.01434.x","article-title":"Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes","volume":"26","author":"Raviv","year":"2012","journal-title":"Clin Transplant"},{"key":"2024102403560862000_30.161.210017.156","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.6.2072"},{"key":"2024102403560862000_30.161.210017.157","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.04.023"},{"issue":"Suppl. 11,","key":"2024102403560862000_30.161.210017.158","doi-asserted-by":"crossref","first-page":"S915","DOI":"10.21037\/jtd.2016.11.05","article-title":"Lung cancer: a rare indication for, but frequent complication after lung transplantation","volume":"8","author":"Van Raemdonck","year":"2016","journal-title":"J Thorac Dis"},{"key":"2024102403560862000_30.161.210017.159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmed.2017.00123","article-title":"Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management","volume":"4","author":"Oldham","year":"2017","journal-title":"Front Med"},{"key":"2024102403560862000_30.161.210017.160","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/ajt.15181","article-title":"Risk of lung cancer in lung transplant recipients in the United States","volume":"19","author":"Triplette","year":"2019","journal-title":"Am J Transplant"},{"key":"2024102403560862000_30.161.210017.161","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.athoracsur.2014.04.014","article-title":"Primary lung cancer in lung transplant recipients","volume":"98","author":"Olland","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2024102403560862000_30.161.210017.162","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1097\/TP.0000000000000673","article-title":"Disease recurrence and acute cellular rejection episodes during the first year after lung transplantation among patients with sarcoidosis","volume":"99","author":"Banga","year":"2015","journal-title":"Transplantation"},{"key":"2024102403560862000_30.161.210017.163","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1164\/ajrccm.156.6.9703001","article-title":"Recurrence of desquamative interstitial pneumonia after lung transplantation","volume":"156","author":"King","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403560862000_30.161.210017.164","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1513\/AnnalsATS.202002-126RL","article-title":"Recurrent pulmonary fibrosis in a lung allograft secondary to de novo antisynthetase syndrome","volume":"17","author":"Scallan","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0017-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:03:19Z","timestamp":1740373399000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0017-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":164,"journal-issue":{"issue":"161","published-online":{"date-parts":[[2021,8,3]]},"published-print":{"date-parts":[[2021,9,30]]}},"alternative-id":["10.1183\/16000617.0017-2021"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0017-2021","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}